As of 2024-12-15, the Relative Valuation of Castle Biosciences Inc (CSTL) is 6.03 USD. This relative valuation is based on P/E multiples. With the latest stock price at 28.87 USD, the upside of Castle Biosciences Inc based on Relative Valuation is -79.1%.
The range of the Relative Valuation is 5.12 - 10.88 USD.
| Range | Selected | |
| Trailing P/E multiples | 27.6x - 50.2x | 30.8x |
| Forward P/E multiples | 23.6x - 32.2x | 24.8x |
| Fair Price | 5.12 - 10.88 | 6.03 |
| Upside | -82.3% - -62.3% | -79.1% |
| Date | P/E |
| 2024-12-13 | 133.11 |
| 2024-12-12 | 134.26 |
| 2024-12-11 | 135.92 |
| 2024-12-10 | 136.62 |
| 2024-12-09 | 142.52 |
| 2024-12-06 | 143.81 |
| 2024-12-05 | 148.28 |
| 2024-12-04 | 146.99 |
| 2024-12-03 | 141.92 |
| 2024-12-02 | 144.78 |
| 2024-11-29 | 139.61 |
| 2024-11-27 | 140.35 |
| 2024-11-26 | 140.95 |
| 2024-11-25 | 136.06 |
| 2024-11-22 | 137.44 |
| 2024-11-21 | 133.16 |
| 2024-11-20 | 131.17 |
| 2024-11-19 | 133.11 |
| 2024-11-18 | 128.64 |
| 2024-11-15 | 129.56 |
| 2024-11-14 | 142.15 |
| 2024-11-13 | 146.62 |
| 2024-11-12 | 151.14 |
| 2024-11-11 | 155.75 |
| 2024-11-08 | 153.49 |
| 2024-11-07 | 153.58 |
| 2024-11-06 | 150.59 |
| 2024-11-05 | 143.62 |
| 2024-11-04 | 155.10 |
| 2024-11-01 | 152.84 |
| 2024-10-31 | 159.85 |
| 2024-10-30 | 159.25 |
| 2024-10-29 | 155.75 |
| 2024-10-28 | 149.39 |
| 2024-10-25 | 144.64 |
| 2024-10-24 | 146.62 |
| 2024-10-23 | 147.17 |
| 2024-10-22 | 148.74 |
| 2024-10-21 | 146.94 |
| 2024-10-18 | 150.49 |
| 2024-10-17 | 152.43 |
| 2024-10-16 | 155.70 |
| 2024-10-15 | 154.37 |
| 2024-10-14 | 157.96 |
| 2024-10-11 | 144.36 |
| 2024-10-10 | 130.48 |
| 2024-10-09 | 132.56 |
| 2024-10-08 | 138.37 |
| 2024-10-07 | 136.11 |
| 2024-10-04 | 135.32 |